SCHEMBL20964483

SCHEMBL20964483

NCCCC[C@H](NC(=O)CCc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(N)=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CALCRL Q16602 2/20 0.53
ROCK2 O75116 1/20 0.49
ITGB3 P05106 1/20 0.49
ITGA2B P08514 1/20 0.49
F2 P00734 1/20 0.49
KISS1R Q969F8 2/20 0.49
ERAP2 Q6P179 1/20 0.48
ERAP1 Q9NZ08 1/20 0.48
LNPEP Q9UIQ6 1/20 0.48
CHRNB2 P17787 1/20 0.48
CHRNB4 P30926 1/20 0.48
CHRNA3 P32297 1/20 0.48
CHRNA4 P43681 1/20 0.48
CPB2 Q96IY4 1/20 0.46
GRIA1 P42261 1/20 0.46
MMP1 P03956 2/20 0.46
MMP3 P08254 2/20 0.46
MMP9 P14780 1/20 0.45
CPA1 P15085 1/20 0.45
CPA2 P48052 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20964452 0.96 CALCRL (0.57) CALCRLITGB3ITGA2BKISS1RGRIA1
SCHEMBL20964480 0.91 CALCRL (0.63) CALCRLROCK2ITGB3ITGA2BKISS1R
SCHEMBL20964475 0.87 CALCRL (0.52) CALCRLROCK2KISS1RCHRNB2CHRNB4
SCHEMBL20964497 0.86 CALCRL (0.58) CALCRLITGB3ITGA2BF2KISS1R
SCHEMBL16908006 0.86 HDAC2 (0.51) ITGB3ITGA2B
SCHEMBL30687362 0.86 HDAC2 (0.51) ITGB3ITGA2B
SCHEMBL20964425 0.86 CALCRL (0.53) CALCRLKISS1RCHRNB2CHRNB4CHRNA3
SCHEMBL20964453 0.85 PTPN1 (0.57) CALCRLITGB3ITGA2BGRIA1PRSS1
SCHEMBL20964479 0.85 CALCRL (0.52) CALCRLKISS1RHRH1
SCHEMBL10088317 0.84 ITGB3 (0.55) CALCRLITGB3ITGA2BF2ERAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11220526-B2 Neuropeptide S receptor (NPSR) agonists RESEARCH TRIANGLE INSTITUTE (US) 2022-01-11 US disclosed
US-20190127419-A1 NEUROPEPTIDE S RECEPTOR (NPSR) AGONISTS RESEARCH TRIANGLE INSTITUTE 2019-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190127419-A1 NEUROPEPTIDE S RECEPTOR (NPSR) AGONISTS NPSR1, GRPR, NPBWR1 CALCRL 116/4885ROCK2 4539/4885ITGB3 2656/4885
US-11220526-B2 Neuropeptide S receptor (NPSR) agonists NPSR1, GRPR, NPBWR1 CALCRL 116/4885ROCK2 4539/4885ITGB3 2656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.